Structure

Physi-Chem Properties

Molecular Weight:  662.38
Volume:  693.467
LogP:  6.635
LogD:  5.084
LogS:  -5.569
# Rotatable Bonds:  5
TPSA:  86.9
# H-Bond Aceptor:  8
# H-Bond Donor:  2
# Rings:  10
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.247
Synthetic Accessibility Score:  7.105
Fsp3:  0.561
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.488
MDCK Permeability:  1.907529804157093e-05
Pgp-inhibitor:  0.176
Pgp-substrate:  0.961
Human Intestinal Absorption (HIA):  0.065
20% Bioavailability (F20%):  0.717
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.785
Plasma Protein Binding (PPB):  89.88713836669922%
Volume Distribution (VD):  2.105
Pgp-substrate:  7.81544828414917%

ADMET: Metabolism

CYP1A2-inhibitor:  0.038
CYP1A2-substrate:  0.917
CYP2C19-inhibitor:  0.515
CYP2C19-substrate:  0.936
CYP2C9-inhibitor:  0.672
CYP2C9-substrate:  0.218
CYP2D6-inhibitor:  0.888
CYP2D6-substrate:  0.917
CYP3A4-inhibitor:  0.93
CYP3A4-substrate:  0.939

ADMET: Excretion

Clearance (CL):  7.016
Half-life (T1/2):  0.029

ADMET: Toxicity

hERG Blockers:  0.929
Human Hepatotoxicity (H-HT):  0.736
Drug-inuced Liver Injury (DILI):  0.382
AMES Toxicity:  0.053
Rat Oral Acute Toxicity:  0.98
Maximum Recommended Daily Dose:  0.993
Skin Sensitization:  0.097
Carcinogencity:  0.589
Eye Corrosion:  0.003
Eye Irritation:  0.005
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478083

Natural Product ID:  NPC478083
Common Name*:   VNPNTCIULDUSTQ-HVIOGEPBSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  VNPNTCIULDUSTQ-HVIOGEPBSA-N
Standard InCHI:  InChI=1S/C41H50N4O4/c1-6-23-14-22-15-31-38(23)45(20-22)13-12-41(31)39(46)30-19-35(48-4)27(17-33(30)43-41)28-16-26-24(7-2)21-44(3)34(36(26)40(47)49-5)18-29-25-10-8-9-11-32(25)42-37(28)29/h7-11,17,19,22-23,26,28,31,34,36,38,42-43H,6,12-16,18,20-21H2,1-5H3/b24-7-/t22-,23-,26+,28+,31+,34-,36-,38-,41-/m0/s1
SMILES:  CC[C@H]1C[C@@H]2CN3[C@@H]1[C@@H](C2)[C@]1(CC3)Nc2c(C1=O)cc(c(c2)[C@H]1C[C@@H]2/C(=CC)/CN([C@H]([C@H]2C(=O)OC)Cc2c1[nH]c1c2cccc1)C)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581906
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0002744] Vobasan alkaloids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[18778099]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. leaf n.a. PMID[18778099]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota Leaves n.a. n.a. PMID[24773071]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota stem-bark Pahang, Malaysia 2003-JUN PMID[25919190]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[26918761]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[27077800]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[29319316]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[30869890]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. PMID[32356659]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9376 Tabernaemontana corymbosa Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 1210.0 nM PMID[453823]
NPT91 Cell Line KB Homo sapiens IC50 = 1060.0 nM PMID[453823]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 8800.0 nM PMID[453824]
NPT858 Cell Line LNCaP Homo sapiens IC50 = 10000.0 nM PMID[453824]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 9400.0 nM PMID[453824]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 7700.0 nM PMID[453824]
NPT81 Cell Line A549 Homo sapiens IC50 = 9100.0 nM PMID[453824]
NPT393 Cell Line HCT-116 Homo sapiens IC50 = 7100.0 nM PMID[453824]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 2900.0 nM PMID[453824]
NPT22764 CELL-LINE KB/VJ300 Homo sapiens IC50 = 9100.0 nM PMID[453824]
NPT2 Others Unspecified IC50 = 8300.0 nM PMID[453824]
NPT22764 CELL-LINE KB/VJ300 Homo sapiens IC50 = 3300.0 nM PMID[453824]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478083 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9091 High Similarity NPC17437
0.9083 High Similarity NPC477067
0.9083 High Similarity NPC478082
0.9039 High Similarity NPC477066
0.9 High Similarity NPC478081
0.8703 High Similarity NPC478080
0.8675 High Similarity NPC473540
0.8523 High Similarity NPC81939
0.8487 Intermediate Similarity NPC475666
0.8478 Intermediate Similarity NPC478078
0.821 Intermediate Similarity NPC96321
0.8062 Intermediate Similarity NPC471304
0.8057 Intermediate Similarity NPC329982
0.8051 Intermediate Similarity NPC311906
0.7983 Intermediate Similarity NPC472099
0.7965 Intermediate Similarity NPC148183
0.7965 Intermediate Similarity NPC152768
0.7949 Intermediate Similarity NPC280799
0.7907 Intermediate Similarity NPC471303
0.7885 Intermediate Similarity NPC300156
0.7875 Intermediate Similarity NPC474192
0.7875 Intermediate Similarity NPC475720
0.7857 Intermediate Similarity NPC157931
0.7835 Intermediate Similarity NPC472098
0.7826 Intermediate Similarity NPC191489
0.7821 Intermediate Similarity NPC473041
0.7802 Intermediate Similarity NPC478074
0.7773 Intermediate Similarity NPC100734
0.7773 Intermediate Similarity NPC477065
0.7773 Intermediate Similarity NPC88923
0.7773 Intermediate Similarity NPC315634
0.7737 Intermediate Similarity NPC39370
0.7735 Intermediate Similarity NPC469928
0.7717 Intermediate Similarity NPC284685
0.7683 Intermediate Similarity NPC475816
0.7665 Intermediate Similarity NPC329793
0.7657 Intermediate Similarity NPC322482
0.7654 Intermediate Similarity NPC473186
0.7652 Intermediate Similarity NPC45190
0.7642 Intermediate Similarity NPC101350
0.7638 Intermediate Similarity NPC53534
0.7627 Intermediate Similarity NPC305984
0.7625 Intermediate Similarity NPC21638
0.7602 Intermediate Similarity NPC235685
0.76 Intermediate Similarity NPC469734
0.7582 Intermediate Similarity NPC49547
0.7576 Intermediate Similarity NPC195788
0.7576 Intermediate Similarity NPC237901
0.7562 Intermediate Similarity NPC74575
0.7561 Intermediate Similarity NPC473187
0.7559 Intermediate Similarity NPC244543
0.7553 Intermediate Similarity NPC169402
0.7551 Intermediate Similarity NPC473105
0.7543 Intermediate Similarity NPC4687
0.7542 Intermediate Similarity NPC144452
0.7531 Intermediate Similarity NPC471762
0.7529 Intermediate Similarity NPC303374
0.7529 Intermediate Similarity NPC152620
0.7521 Intermediate Similarity NPC46561
0.75 Intermediate Similarity NPC39500
0.749 Intermediate Similarity NPC257851
0.749 Intermediate Similarity NPC208522
0.748 Intermediate Similarity NPC329631
0.747 Intermediate Similarity NPC270515
0.7469 Intermediate Similarity NPC474688
0.7468 Intermediate Similarity NPC116238
0.7468 Intermediate Similarity NPC321428
0.7463 Intermediate Similarity NPC260909
0.7459 Intermediate Similarity NPC274640
0.7459 Intermediate Similarity NPC194740
0.7458 Intermediate Similarity NPC323969
0.745 Intermediate Similarity NPC142385
0.7449 Intermediate Similarity NPC470018
0.7418 Intermediate Similarity NPC470126
0.7415 Intermediate Similarity NPC87413
0.7397 Intermediate Similarity NPC280272
0.7393 Intermediate Similarity NPC478075
0.739 Intermediate Similarity NPC15801
0.7388 Intermediate Similarity NPC66777
0.7388 Intermediate Similarity NPC253580
0.7386 Intermediate Similarity NPC174760
0.7375 Intermediate Similarity NPC184408
0.7373 Intermediate Similarity NPC470020
0.7366 Intermediate Similarity NPC122436
0.7364 Intermediate Similarity NPC330009
0.7346 Intermediate Similarity NPC89549
0.7342 Intermediate Similarity NPC208284
0.7342 Intermediate Similarity NPC9894
0.7341 Intermediate Similarity NPC72905
0.7338 Intermediate Similarity NPC227824
0.7333 Intermediate Similarity NPC63971
0.7333 Intermediate Similarity NPC91868
0.7328 Intermediate Similarity NPC260434
0.7328 Intermediate Similarity NPC132385
0.732 Intermediate Similarity NPC6786
0.7319 Intermediate Similarity NPC249583
0.7314 Intermediate Similarity NPC276657
0.7314 Intermediate Similarity NPC225279
0.7311 Intermediate Similarity NPC308137
0.7311 Intermediate Similarity NPC310211
0.7302 Intermediate Similarity NPC148889
0.7302 Intermediate Similarity NPC475844
0.7298 Intermediate Similarity NPC207686
0.7294 Intermediate Similarity NPC218388
0.7291 Intermediate Similarity NPC41679
0.7284 Intermediate Similarity NPC198503
0.7284 Intermediate Similarity NPC329747
0.728 Intermediate Similarity NPC477549
0.7276 Intermediate Similarity NPC137353
0.7273 Intermediate Similarity NPC74360
0.7269 Intermediate Similarity NPC22481
0.7269 Intermediate Similarity NPC187501
0.7258 Intermediate Similarity NPC477531
0.7255 Intermediate Similarity NPC178858
0.7251 Intermediate Similarity NPC470022
0.7251 Intermediate Similarity NPC184680
0.7249 Intermediate Similarity NPC472210
0.7249 Intermediate Similarity NPC269886
0.7249 Intermediate Similarity NPC247735
0.7249 Intermediate Similarity NPC81802
0.7249 Intermediate Similarity NPC472295
0.7247 Intermediate Similarity NPC252251
0.7243 Intermediate Similarity NPC150239
0.7243 Intermediate Similarity NPC477533
0.7238 Intermediate Similarity NPC473180
0.7238 Intermediate Similarity NPC94157
0.7224 Intermediate Similarity NPC51388
0.7222 Intermediate Similarity NPC470785
0.7222 Intermediate Similarity NPC470784
0.722 Intermediate Similarity NPC183407
0.7218 Intermediate Similarity NPC24019
0.7218 Intermediate Similarity NPC209174
0.7215 Intermediate Similarity NPC39679
0.7215 Intermediate Similarity NPC475910
0.721 Intermediate Similarity NPC249040
0.7206 Intermediate Similarity NPC314222
0.7206 Intermediate Similarity NPC196449
0.7202 Intermediate Similarity NPC208084
0.7197 Intermediate Similarity NPC220337
0.7191 Intermediate Similarity NPC476098
0.7189 Intermediate Similarity NPC475253
0.7185 Intermediate Similarity NPC476116
0.7184 Intermediate Similarity NPC210434
0.7183 Intermediate Similarity NPC189903
0.7183 Intermediate Similarity NPC182907
0.7178 Intermediate Similarity NPC118228
0.7177 Intermediate Similarity NPC314954
0.7177 Intermediate Similarity NPC33949
0.7167 Intermediate Similarity NPC264176
0.7166 Intermediate Similarity NPC227908
0.7161 Intermediate Similarity NPC132539
0.716 Intermediate Similarity NPC303658
0.716 Intermediate Similarity NPC247803
0.7149 Intermediate Similarity NPC102338
0.7149 Intermediate Similarity NPC63199
0.7149 Intermediate Similarity NPC111602
0.7149 Intermediate Similarity NPC278525
0.7149 Intermediate Similarity NPC3207
0.7149 Intermediate Similarity NPC196251
0.7143 Intermediate Similarity NPC470017
0.7143 Intermediate Similarity NPC131017
0.7143 Intermediate Similarity NPC108342
0.7143 Intermediate Similarity NPC133609
0.7137 Intermediate Similarity NPC160381
0.7131 Intermediate Similarity NPC288987
0.7126 Intermediate Similarity NPC471583
0.7126 Intermediate Similarity NPC115588
0.7126 Intermediate Similarity NPC471782
0.712 Intermediate Similarity NPC474701
0.7119 Intermediate Similarity NPC162484
0.7118 Intermediate Similarity NPC329858
0.7115 Intermediate Similarity NPC189079
0.7114 Intermediate Similarity NPC216612
0.7113 Intermediate Similarity NPC201697
0.7112 Intermediate Similarity NPC472293
0.7112 Intermediate Similarity NPC472116
0.7104 Intermediate Similarity NPC26543
0.7104 Intermediate Similarity NPC165964
0.7102 Intermediate Similarity NPC86078
0.7101 Intermediate Similarity NPC193777
0.7101 Intermediate Similarity NPC270918
0.7095 Intermediate Similarity NPC473493
0.7092 Intermediate Similarity NPC196718
0.7092 Intermediate Similarity NPC207620
0.7092 Intermediate Similarity NPC102593
0.7092 Intermediate Similarity NPC139373
0.7087 Intermediate Similarity NPC278540
0.7083 Intermediate Similarity NPC234999
0.708 Intermediate Similarity NPC176127
0.7077 Intermediate Similarity NPC473800
0.7077 Intermediate Similarity NPC473188
0.7076 Intermediate Similarity NPC162730
0.7075 Intermediate Similarity NPC295228
0.7073 Intermediate Similarity NPC60621
0.7073 Intermediate Similarity NPC477532
0.7069 Intermediate Similarity NPC276517
0.7068 Intermediate Similarity NPC473185
0.7067 Intermediate Similarity NPC169716
0.7066 Intermediate Similarity NPC469592
0.7066 Intermediate Similarity NPC471080

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478083 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9091 High Similarity NPD8358 Approved
0.7826 Intermediate Similarity NPD7708 Approved
0.7773 Intermediate Similarity NPD7803 Approved
0.7752 Intermediate Similarity NPD8364 Approved
0.7752 Intermediate Similarity NPD8363 Approved
0.7717 Intermediate Similarity NPD7956 Approved
0.7717 Intermediate Similarity NPD7955 Approved
0.7692 Intermediate Similarity NPD8365 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD6242 Discontinued
0.7671 Intermediate Similarity NPD5488 Discontinued
0.766 Intermediate Similarity NPD3393 Approved
0.766 Intermediate Similarity NPD3389 Approved
0.766 Intermediate Similarity NPD3394 Approved
0.7654 Intermediate Similarity NPD4885 Approved
0.7631 Intermediate Similarity NPD5483 Clinical (unspecified phase)
0.7621 Intermediate Similarity NPD4118 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD8466 Approved
0.7576 Intermediate Similarity NPD8465 Approved
0.7576 Intermediate Similarity NPD8467 Approved
0.7572 Intermediate Similarity NPD4952 Phase 3
0.7562 Intermediate Similarity NPD7994 Phase 2
0.7562 Intermediate Similarity NPD7268 Clinical (unspecified phase)
0.7542 Intermediate Similarity NPD6160 Clinical (unspecified phase)
0.7539 Intermediate Similarity NPD8091 Phase 3
0.7528 Intermediate Similarity NPD8425 Approved
0.7528 Intermediate Similarity NPD8426 Approved
0.7521 Intermediate Similarity NPD5632 Approved
0.7509 Intermediate Similarity NPD8427 Approved
0.7509 Intermediate Similarity NPD8429 Approved
0.7509 Intermediate Similarity NPD8428 Approved
0.7489 Intermediate Similarity NPD6567 Clinical (unspecified phase)
0.748 Intermediate Similarity NPD6741 Clinical (unspecified phase)
0.748 Intermediate Similarity NPD4373 Phase 2
0.7463 Intermediate Similarity NPD8460 Approved
0.7463 Intermediate Similarity NPD8459 Approved
0.744 Intermediate Similarity NPD6790 Phase 1
0.7429 Intermediate Similarity NPD5479 Discontinued
0.7422 Intermediate Similarity NPD8463 Approved
0.7419 Intermediate Similarity NPD3006 Discontinued
0.74 Intermediate Similarity NPD8016 Phase 3
0.74 Intermediate Similarity NPD8017 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD5482 Discontinued
0.7362 Intermediate Similarity NPD2509 Approved
0.7362 Intermediate Similarity NPD2510 Approved
0.7342 Intermediate Similarity NPD5416 Discontinued
0.7333 Intermediate Similarity NPD8102 Discontinued
0.7331 Intermediate Similarity NPD2921 Clinical (unspecified phase)
0.7328 Intermediate Similarity NPD7688 Phase 1
0.7325 Intermediate Similarity NPD6824 Clinical (unspecified phase)
0.7322 Intermediate Similarity NPD5293 Phase 2
0.7287 Intermediate Similarity NPD5801 Clinical (unspecified phase)
0.728 Intermediate Similarity NPD7853 Phase 2
0.728 Intermediate Similarity NPD6531 Approved
0.728 Intermediate Similarity NPD6530 Approved
0.7276 Intermediate Similarity NPD3259 Approved
0.7276 Intermediate Similarity NPD7690 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD4987 Clinical (unspecified phase)
0.7266 Intermediate Similarity NPD4558 Phase 2
0.725 Intermediate Similarity NPD3257 Approved
0.725 Intermediate Similarity NPD5417 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD7417 Discontinued
0.7231 Intermediate Similarity NPD4429 Discontinued
0.7229 Intermediate Similarity NPD7797 Approved
0.7229 Intermediate Similarity NPD7796 Approved
0.7215 Intermediate Similarity NPD5658 Approved
0.7202 Intermediate Similarity NPD6770 Approved
0.7202 Intermediate Similarity NPD3258 Approved
0.719 Intermediate Similarity NPD7823 Clinical (unspecified phase)
0.718 Intermediate Similarity NPD7925 Phase 2
0.718 Intermediate Similarity NPD7924 Phase 2
0.7178 Intermediate Similarity NPD7538 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD8489 Phase 1
0.716 Intermediate Similarity NPD7395 Discontinued
0.7154 Intermediate Similarity NPD4926 Clinical (unspecified phase)
0.7131 Intermediate Similarity NPD5040 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD4958 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7710 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7454 Approved
0.7095 Intermediate Similarity NPD7455 Approved
0.7075 Intermediate Similarity NPD5891 Approved
0.707 Intermediate Similarity NPD6716 Phase 1
0.7069 Intermediate Similarity NPD4418 Discontinued
0.7064 Intermediate Similarity NPD4501 Approved
0.7064 Intermediate Similarity NPD4500 Approved
0.7054 Intermediate Similarity NPD8100 Phase 3
0.7046 Intermediate Similarity NPD2121 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD7219 Approved
0.7045 Intermediate Similarity NPD7221 Approved
0.7041 Intermediate Similarity NPD5450 Discontinued
0.7 Intermediate Similarity NPD2916 Discontinued
0.7 Intermediate Similarity NPD4328 Approved
0.7 Intermediate Similarity NPD6376 Discontinued
0.6992 Remote Similarity NPD7404 Approved
0.6989 Remote Similarity NPD7393 Clinical (unspecified phase)
0.6988 Remote Similarity NPD6247 Clinical (unspecified phase)
0.6987 Remote Similarity NPD5530 Phase 1
0.6984 Remote Similarity NPD6962 Phase 2
0.6983 Remote Similarity NPD7470 Discontinued
0.6983 Remote Similarity NPD5475 Discontinued
0.6976 Remote Similarity NPD6995 Phase 1
0.6973 Remote Similarity NPD8101 Phase 3
0.697 Remote Similarity NPD4499 Approved
0.6961 Remote Similarity NPD8524 Approved
0.6955 Remote Similarity NPD8096 Phase 3
0.6955 Remote Similarity NPD8097 Phase 3
0.6955 Remote Similarity NPD5866 Approved
0.6955 Remote Similarity NPD6228 Discontinued
0.6948 Remote Similarity NPD7547 Clinical (unspecified phase)
0.6946 Remote Similarity NPD3947 Discontinued
0.6944 Remote Similarity NPD7589 Clinical (unspecified phase)
0.6944 Remote Similarity NPD5022 Discontinued
0.6939 Remote Similarity NPD8160 Phase 2
0.6923 Remote Similarity NPD3324 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4368 Phase 2
0.6908 Remote Similarity NPD6209 Approved
0.6902 Remote Similarity NPD2951 Discontinued
0.6901 Remote Similarity NPD4506 Discontinued
0.6892 Remote Similarity NPD8289 Discontinued
0.689 Remote Similarity NPD5151 Clinical (unspecified phase)
0.689 Remote Similarity NPD6263 Clinical (unspecified phase)
0.6888 Remote Similarity NPD5429 Discontinued
0.6888 Remote Similarity NPD7222 Phase 2
0.6885 Remote Similarity NPD6657 Clinical (unspecified phase)
0.6884 Remote Similarity NPD8279 Clinical (unspecified phase)
0.6882 Remote Similarity NPD6503 Clinical (unspecified phase)
0.688 Remote Similarity NPD1038 Approved
0.688 Remote Similarity NPD1304 Clinical (unspecified phase)
0.6875 Remote Similarity NPD6138 Clinical (unspecified phase)
0.6873 Remote Similarity NPD7392 Phase 2
0.686 Remote Similarity NPD7025 Clinical (unspecified phase)
0.686 Remote Similarity NPD4561 Discontinued
0.6857 Remote Similarity NPD3945 Discontinued
0.6855 Remote Similarity NPD7194 Discontinued
0.6853 Remote Similarity NPD3925 Approved
0.685 Remote Similarity NPD7689 Approved
0.6849 Remote Similarity NPD484 Approved
0.6849 Remote Similarity NPD4601 Approved
0.6849 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6849 Remote Similarity NPD4600 Approved
0.6846 Remote Similarity NPD8403 Phase 1
0.6846 Remote Similarity NPD3003 Approved
0.6827 Remote Similarity NPD7858 Clinical (unspecified phase)
0.6818 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6815 Remote Similarity NPD3354 Phase 2
0.6815 Remote Similarity NPD7878 Phase 2
0.6805 Remote Similarity NPD3946 Clinical (unspecified phase)
0.6805 Remote Similarity NPD5901 Discontinued
0.6805 Remote Similarity NPD4795 Phase 2
0.6803 Remote Similarity NPD7998 Clinical (unspecified phase)
0.68 Remote Similarity NPD5507 Approved
0.68 Remote Similarity NPD5506 Approved
0.6798 Remote Similarity NPD4845 Discontinued
0.6798 Remote Similarity NPD6292 Clinical (unspecified phase)
0.6797 Remote Similarity NPD7951 Approved
0.6797 Remote Similarity NPD7790 Approved
0.6797 Remote Similarity NPD7950 Approved
0.6797 Remote Similarity NPD7953 Approved
0.6797 Remote Similarity NPD7791 Approved
0.6797 Remote Similarity NPD7789 Approved
0.6797 Remote Similarity NPD7952 Approved
0.6793 Remote Similarity NPD5003 Discontinued
0.6792 Remote Similarity NPD6724 Clinical (unspecified phase)
0.6787 Remote Similarity NPD5519 Discontinued
0.6787 Remote Similarity NPD3763 Approved
0.678 Remote Similarity NPD6861 Clinical (unspecified phase)
0.678 Remote Similarity NPD6525 Clinical (unspecified phase)
0.6777 Remote Similarity NPD7010 Phase 3
0.6772 Remote Similarity NPD5559 Phase 2
0.6769 Remote Similarity NPD5473 Discontinued
0.6766 Remote Similarity NPD5867 Clinical (unspecified phase)
0.6765 Remote Similarity NPD7889 Clinical (unspecified phase)
0.6763 Remote Similarity NPD6176 Phase 1
0.6761 Remote Similarity NPD5903 Approved
0.6761 Remote Similarity NPD5902 Approved
0.676 Remote Similarity NPD5930 Phase 3
0.6758 Remote Similarity NPD3746 Discontinued
0.6757 Remote Similarity NPD7729 Clinical (unspecified phase)
0.6753 Remote Similarity NPD6456 Discontinued
0.6748 Remote Similarity NPD7069 Discontinued
0.6747 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6742 Remote Similarity NPD7658 Phase 2
0.6738 Remote Similarity NPD8525 Approved
0.6738 Remote Similarity NPD4948 Discontinued
0.6736 Remote Similarity NPD8115 Approved
0.6736 Remote Similarity NPD7176 Clinical (unspecified phase)
0.6736 Remote Similarity NPD8114 Approved
0.6734 Remote Similarity NPD5612 Discontinued
0.6732 Remote Similarity NPD7558 Phase 2
0.6731 Remote Similarity NPD7885 Phase 2
0.6731 Remote Similarity NPD7886 Phase 2
0.6723 Remote Similarity NPD5912 Clinical (unspecified phase)
0.6723 Remote Similarity NPD5913 Phase 3
0.6721 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6719 Remote Similarity NPD7586 Clinical (unspecified phase)
0.6717 Remote Similarity NPD3986 Discontinued
0.6714 Remote Similarity NPD7766 Phase 2
0.6708 Remote Similarity NPD3507 Phase 2
0.6705 Remote Similarity NPD7868 Clinical (unspecified phase)
0.6705 Remote Similarity NPD6276 Discontinued
0.6703 Remote Similarity NPD6773 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data